3.61% -0.185

Verve Therapeutics Inc (VERV)

Verve Therapeutics Inc Aktie (VERV) Neueste Nachrichten

Verve Therapeutics Inc (VERV)

Verve Therapeutics Inc Aktie (VERV) Neueste Nachrichten

VERVE THERAPEUTICS, INC. (NASDAQ: VERV) DEADLINE ALERT: - GlobeNewswire

VERVE THERAPEUTICS, INC. (NASDAQ: VERV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Verve - The Bakersfield Californian

Analyzing Ratios: Verve Therapeutics Inc (VERV)’s Financial Story Unveiled - The Dwinnex

Verve Therapeutics Inc (VERV)’s stock price range in the last year - US Post News

7 Best NASDAQ Stocks Under $5 - Insider Monkey

ROSEN, A LEADING NATIONAL FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel - The Bakersfield Californian

ROSEN, A LEADING NATIONAL FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV - GlobeNewswire Inc.

VERV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Shareholders that lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about pending Class ActionVERV - PR Newswire

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire

VERV Stock Sees Decline of Approximately -13.43% in Last Five Days - Knox Daily

Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024VERV - Lelezard

VERV SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - GlobeNewswire Inc.

Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024VERV - Morningstar

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics - Daily Guardian Canada

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics - GlobeNewswire

Verve Therapeutics Inc (VERV) is looking forward to a strong quarter - SETE News

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Verve Therapeutics, Inc.VERV - PR Newswire

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm - PR Newswire

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics - Stockhouse Publishing

VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Was there any good news for Verve Therapeutics Inc (VERV) stock in the last session? - US Post News

Levi & Korsinsky Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit - Stockhouse Publishing

Investing in Verve Therapeutics Inc (VERV) Is Getting More Attractive - Knox Daily

Ratios in Focus: Analyzing Verve Therapeutics Inc (VERV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

VERV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

The Gross Law Firm Reminds Verve Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024VERV - PR Newswire

VERVE THERAPEUTICS, INC. (NASDAQ: VERV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Verve Therapeutics, Inc. Investors of Upcoming Deadline - ForexTV.com

2024-09-22 | SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics | NDAQ:VERV | Press Release - Stockhouse Publishing

DekaBank Deutsche Girozentrale Sells 2,690 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verve - GlobeNewswire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV - GlobeNewswire Inc.

Jim Cramer on Vertiv Holdings (VRT): ‘I Think It’s A Winner’ - Yahoo Finance

VERV SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

VERV’s Stochastic Averages Dip: Analyzing Verve Therapeutics Inc’s Stock Performance - The InvestChronicle

Jim Cramer on Verve Therapeutics Inc. (VERV): ‘I Think It’s A Winner’ - Insider Monkey

Insider Buying: Ashe Andrew D., Verve Therapeutics Inc [VERV] insider invested 76,000 shares - Knox Daily

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics - GlobeNewswire

VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics LawsuitVERV - PR Newswire

Verve Therapeutics, Inc. (NASDAQ:VERV) Position Trimmed by Federated Hermes Inc. - MarketBeat

Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – VERV - MSN

Views of Wall Street’s Leading Experts on Verve Therapeutics Inc - SETE News

Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – VERV - ForexTV.com

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Acquired by Daiwa Securities Group Inc. - Defense World

Shareholders that lost money on Verve Therapeutics, Inc.(VERV) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - Invezz

VERV CLASS ACTION: Verve Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit - ForexTV.com

VERV CLASS ACTION: Verve Therapeutics, Inc. Stockholders - GlobeNewswire

VERV CLASS ACTION: Verve Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit - GlobeNewswire Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Verve Therapeutics, Inc. - Longview News-Journal

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Verve - GlobeNewswire

How should investors view Verve Therapeutics Inc (VERV)? - US Post News

VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Shareholders that lost money on Verve Therapeutics, Inc.(VERV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - PR Newswire

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics LawsuitVERV - The Malaysian Reserve

Ratios Revealed: Decoding Verve Therapeutics Inc (VERV)’s Financial Health - The Dwinnex

Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for InvestorsContact Levi & Korsinsky - Kilgore News Herald

Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for InvestorsContact Levi & Korsinsky - The Malaysian Reserve

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Verve - GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV - GlobeNewswire Inc.

Faruqi & Faruqi Reminds Verve Therapeutics Investors of the - GlobeNewswire

Faruqi & Faruqi Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024VERV - Morningstar

Ähnlich wie VERV